Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

  • 0Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

|

Summary

No abstract available on PubMed